About Synthex Labs
Synthex Labs is a company based in San Francisco (United States) founded in 2016. Synthex Labs has raised $10.37 million across 3 funding rounds from investors including IndieBio. The company has 15 employees. Synthex Labs offers products and services including Tor FLEx Platform, ToRPPIDO, and ToRNeDO. Synthex Labs operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter San Francisco, United States
- Employees 15
- SectorsHealthcare
- Website synthexlabs.com
- Social LinkedIn X
- Legal Name Synthex, Inc.
- Total Equity Funding$10.37M (USD)
in 3 rounds
- Latest Funding Round$5.18M (USD), Series A
Dec 2023
- Investors
- Employee Count15
Products & Services of Synthex Labs
Synthex Labs offers a comprehensive portfolio of products and services, including Tor FLEx Platform, ToRPPIDO, and ToRNeDO.
Engineers cells to identify drugs for challenging protein targets.
Supports oncology drug development through functional selection.
Facilitates exploration of novel drug mechanisms in pipelines.
Funding Insights of Synthex Labs
Synthex Labs has successfully raised a total of $10.37M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.18 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.37M
- Total Rounds 3
- Last Round Series A — $5.18M
- First Round $250,000
(Oct 2016)
- Investors Count 1
All 3 funding rounds of Synthex Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $5.18M | Series A | – | – | – |
| Mar 2017 | $4.94M | Series A | – | – | – |
| Oct 2016 | $250,000 | Seed | – | IndieBio | – |
1 investors in total: 1 institutional.
Investors in Synthex Labs
Synthex Labs has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | – | indiebio.co | San Francisco, United States |
Investor details for Synthex Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Synthex Labs
9 people are tracked at Synthex Labs (4 in leadership, 2 in board & advisors, 3 in team); the tracked headcount is 15.
| Name | Role | Group |
|---|---|---|
Charly Chahwan | Co-Founder & Chief Science Officer | Leadership |
Tri Luong | Head of Finance & Operations | Leadership |
Maria Soloveychik | Co-founder, CEO | Leadership |
Rachel Bond, PhD | Head of Discovery Platforms | Leadership |
Leonard Post | Advisor | Board & advisors |
Andrew Perlman | Advisor | Board & advisors |
Ainsley Underhill | Lead Cell Biologist | Team |
Ameya Limaye | Research Scientist II | Team |
Sabrina Lin | Research Assistant | Team |
Complete people profiles for Synthex Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Synthex Labs
3 dated milestones of Synthex Labs across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Synthex Labs is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series A, of $5.2M.
Competitors of Synthex Labs
Synthex Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| jazzpharma.com | 2003 | Dublin, Ireland | $265M | 2,800 | Novel biopharmaceutical medicines are developed for unmet medical needs. | |
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| adacap.com | 2002 | Saint Genis Pouilly, France | $56.13M | – | Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | |
| incyte.com | 1991 | Wilmington, United States | – | 1,387 | Small molecules are developed for cancer and skin disease treatments. | |
| revmed.com | 2014 | Redwood, United States | $326.29M | 181 | Cancer therapies are developed using selective pathway inhibitors. | |
| blueprintmedicines.com | 2008 | Cambridge, United States | $115M | 201 | Selective kinase inhibitors are developed for genomically defined cancers. | |
| syndax.com | 2005 | Waltham, United States | $198.29M | 107 | Targeted therapies for cancer treatment are developed. | |
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. |
Detailed competitors of Synthex Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synthex Labs
Websites that share an audience with Synthex Labs (synthexlabs.com).
Websites whose visitors overlap most with Synthex Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| xcellbio.com | 100% | 4.4K | #4,847,582 | View details | |
| mandalmed.com | 100% | 1.3K | #14,142,095 | View details | |
| titanpharm.com | 100% | 4.3K | #4,063,501 | View details | |
| corvuspharma.com | 98% | 13.6K | #3,366,661 | View details | |
bplifescience.com | bplifescience.com | 97% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 29 similar websites and full traffic analytics for Synthex Labs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 29 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Synthex Labs
Complete news archive for Synthex Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Synthex Labs
10 companies that operate in the same segment as Synthex Labs (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synthex Labs
Synthex Labs was founded in 2016.
Synthex Labs is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Synthex Labs is a funded company, having raised a total of $10.37M across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Oct 2016.
Synthex Labs has 15 employees.
Synthex Labs was founded in 2016 and is based in San Francisco, United States. Peptide therapeutics targeting cancer and rare diseases are developed through a proprietary platform involving an engineered microbe. Natural and synthetic peptides are screened to disrupt protein-protein interactions, facilitating drug development for undruggable disorders. The initial focus is on cancers like intrahepatic cholangiocarcinomas, with the lead compound in preclinical testing.
Synthex Labs's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Synthex Labs offers Tor FLEx Platform, ToRPPIDO, and ToRNeDO.
Synthex Labs has 1 investor. Key investors include IndieBio.
Synthex Labs operates through Synthex, Inc..